Literature DB >> 21707592

Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection.

D Li1, J Chen, M Jia, K Hong, Y Ruan, H Liang, S Liu, X Zhang, H Zhao, H Peng, P Ma, Y Shao.   

Abstract

The aim of this study is to characterize the changes of CD4(+) CD25(high) forkhead box P3 (FoxP3(+) ) regulatory T cells (T(reg) ), interleukin (IL)-17 secreting T helper type 17 (Th17) cell frequencies and the balance of these two subsets in a cohort of chronic human immunodeficiency virus type 1 (HIV-1)-infected patients in China. A total of 115 untreated chronic HIV-infected individuals and 32 healthy donors were recruited in this study. Peripheral blood mononuclear cells were isolated from ethylenediamine tetracetic acid (EDTA) anti-coagulated fresh whole blood and stained to characterize the frequencies of T(reg) and Th17. Of a total 115 patients, 42 individuals including 10 elite controllers were followed-up for more than 1 year, and changes of T(reg) and Th17 frequencies were analysed over time. The continuous loss of Th17 cells was accompanied by a concomitant rise in the frequency of T(reg) cells, resulting in a loss of Th17/T(reg) balance during the progressive HIV infection. Meanwhile, the T(reg) levels, Th17 levels and Th17/T(reg) ratios of the elite controller group were comparable to those of the HIV-1 negative controls in the follow-up study. Additionally, we demonstrated that loss of balance between Th17 and T(reg) is associated with an earlier CD4 T cell decline during the course of HIV infection. Our results indicate that a loss of immune-balance of Th17 to T(reg) during HIV-1 disease progression and the persistence of such an immune-balance in the elite controllers may have a critical role in HIV-1 infection and further shed new light into understanding the pathogenesis of HIV-1.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Year:  2011        PMID: 21707592      PMCID: PMC3170985          DOI: 10.1111/j.1365-2249.2011.04435.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China.

Authors:  Bo Su; Li Liu; Fusheng Wang; Xien Gui; Min Zhao; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

2.  Depletion of regulatory T cells in HIV infection is associated with immune activation.

Authors:  Mark P Eggena; Banson Barugahare; Norman Jones; Martin Okello; Steven Mutalya; Cissy Kityo; Peter Mugyenyi; Huyen Cao
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

Review 3.  Regulatory T cells: friend or foe in immunity to infection?

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

Review 4.  Th17 and regulatory T cells: implications for AIDS pathogenesis.

Authors:  Bittoo Kanwar; David Favre; Joseph M McCune
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

5.  Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.

Authors:  Linqi Zhang; Zhiwei Chen; Yunzhen Cao; Jian Yu; Guanghan Li; Wenjie Yu; Ning Yin; Shan Mei; Li Li; Peter Balfe; Tian He; Lei Ba; Fengwen Zhang; His-Hsun Lin; Man-Fung Yuen; Ching-Lung Lai; David D Ho
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

7.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

8.  Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Authors:  M Hellerstein; M B Hanley; D Cesar; S Siler; C Papageorgopoulos; E Wieder; D Schmidt; R Hoh; R Neese; D Macallan; S Deeks; J M McCune
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

9.  Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

Authors:  Laurence Weiss; Vladimira Donkova-Petrini; Laure Caccavelli; Michèle Balbo; Cédric Carbonneil; Yves Levy
Journal:  Blood       Date:  2004-07-22       Impact factor: 22.113

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  16 in total

1.  Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.

Authors:  M Márquez-Coello; M Montes-de-Oca Arjona; C Fernández-Gutiérrez Del Álamo; C Ruiz-Sánchez; J A Girón-González
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

2.  Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

Authors:  M Jia; D Li; X He; Y Zhao; H Peng; P Ma; K Hong; H Liang; Y Shao
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

3.  Th17 and Th17/Treg ratio at early HIV infection associate with protective HIV-specific CD8(+) T-cell responses and disease progression.

Authors:  Juliana Falivene; Yanina Ghiglione; Natalia Laufer; María Eugenia Socías; María Pía Holgado; María Julia Ruiz; Cynthia Maeto; María Inés Figueroa; Luis D Giavedoni; Pedro Cahn; Horacio Salomón; Omar Sued; Gabriela Turk; María Magdalena Gherardi
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

Review 4.  Immunogenetics of small ruminant lentiviral infections.

Authors:  Nancy Stonos; Sarah K Wootton; Niel Karrow
Journal:  Viruses       Date:  2014-08-22       Impact factor: 5.048

Review 5.  Th17 cells in autoimmune and infectious diseases.

Authors:  José Francisco Zambrano-Zaragoza; Enrique Jhonatan Romo-Martínez; Ma de Jesús Durán-Avelar; Noemí García-Magallanes; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2014-08-03

6.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

Review 7.  New Insights about Treg and Th17 Cells in HIV Infection and Disease Progression.

Authors:  Jacqueline María Valverde-Villegas; Maria Cristina Cotta Matte; Rúbia Marília de Medeiros; José Artur Bogo Chies
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

8.  Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy.

Authors:  Claudia Stuehler; Claudia Bernardini; Luigia Elzi; Marcel Stoeckle; Stefan Zimmerli; Hansjakob Furrer; Huldrych F Günthard; Salomé Leibundgut-Landmann; Manuel Battegay; Nina Khanna
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

9.  Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation.

Authors:  Pushpa Pandiyan; Souheil-Antoine Younes; Susan Pereira Ribeiro; Aarthi Talla; David McDonald; Natarajan Bhaskaran; Alan D Levine; Aaron Weinberg; Rafick P Sekaly
Journal:  Front Immunol       Date:  2016-06-20       Impact factor: 7.561

10.  Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy.

Authors:  Rafiq Nabi; Zina Moldoveanu; Qing Wei; Elizabeth T Golub; Helen G Durkin; Ruth M Greenblatt; Betsy C Herold; Marek J Nowicki; Seble Kassaye; Michael W Cho; Abraham Pinter; Alan L Landay; Jiri Mestecky; Pamela A Kozlowski
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.